Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2023

Author: Benzinga Insights | March 08, 2023 11:00am

Upgrades

For Nordstrom Inc (NYSE:JWN), Argus Research upgraded the previous rating of Hold to Buy. In the fourth quarter, Nordstrom showed an EPS of $0.74, compared to $1.23 from the year-ago quarter. At the moment, the stock has a 52-week-high of $29.59 and a 52-week-low of $15.53. Nordstrom closed at $19.53 at the end of the last trading period.

According to B of A Securities, the prior rating for Atlantica Sustainable Infrastructure PLC (NASDAQ:AY) was changed from Neutral to Buy. Atlantica Sustainable earned $0.03 in the fourth quarter, compared to $0.10 in the year-ago quarter. At the moment, the stock has a 52-week-high of $36.85 and a 52-week-low of $24.42. Atlantica Sustainable closed at $28.08 at the end of the last trading period.

According to B of A Securities, the prior rating for CMS Energy Corp (NYSE:CMS) was changed from Neutral to Buy. For the fourth quarter, CMS Energy had an EPS of $0.60, compared to year-ago quarter EPS of $0.47. At the moment, the stock has a 52-week-high of $73.76 and a 52-week-low of $52.41. CMS Energy closed at $58.93 at the end of the last trading period.

According to JP Morgan, the prior rating for AGNC Investment Corp (NASDAQ:AGNC) was changed from Neutral to Overweight. In the fourth quarter, AGNC Investment showed an EPS of $0.74, compared to $0.75 from the year-ago quarter. At the moment, the stock has a 52-week-high of $13.64 and a 52-week-low of $7.30. AGNC Investment closed at $10.59 at the end of the last trading period.

See all analyst ratings upgrades.

Downgrades

Truist Securities downgraded the previous rating for TCR2 Therapeutics Inc (NASDAQ:TCRR) from Buy to Hold. In the third quarter, TCR2 Therapeutics showed an EPS of $0.79, compared to $0.69 from the year-ago quarter. The stock has a 52-week-high of $3.88 and a 52-week-low of $0.82. At the end of the last trading period, TCR2 Therapeutics closed at $1.60.

According to JP Morgan, the prior rating for TDCX Inc (NYSE:TDCX) was changed from Overweight to Neutral. In the fourth quarter, TDCX showed an EPS of $0.15, compared to $0.15 from the year-ago quarter. The stock has a 52-week-high of $15.38 and a 52-week-low of $6.52. At the end of the last trading period, TDCX closed at $13.09.

For WW International Inc (NASDAQ:WW), Craig-Hallum downgraded the previous rating of Hold to Sell. WW International earned $0.01 in the fourth quarter, compared to $0.35 in the year-ago quarter. The stock has a 52-week-high of $11.03 and a 52-week-low of $3.28. At the end of the last trading period, WW International closed at $6.93.

For Centene Corp (NYSE:CNC), Deutsche Bank downgraded the previous rating of Buy to Hold. For the fourth quarter, Centene had an EPS of $0.86, compared to year-ago quarter EPS of $1.01. The current stock performance of Centene shows a 52-week-high of $98.53 and a 52-week-low of $67.39. Moreover, at the end of the last trading period, the closing price was at $67.95.

According to Odeon Capital, the prior rating for Bank of America Corp (NYSE:BAC) was changed from Buy to Hold. Bank of America earned $0.85 in the fourth quarter, compared to $0.82 in the year-ago quarter. The stock has a 52-week-high of $44.63 and a 52-week-low of $29.31. At the end of the last trading period, Bank of America closed at $33.00.

For Offerpad Solutions Inc (NYSE:OPAD), JP Morgan downgraded the previous rating of Overweight to Neutral. Offerpad Solutions earned $0.50 in the fourth quarter, compared to $0.11 in the year-ago quarter. The current stock performance of Offerpad Solutions shows a 52-week-high of $6.37 and a 52-week-low of $0.38. Moreover, at the end of the last trading period, the closing price was at $0.57.

Canaccord Genuity downgraded the previous rating for Qualtrics International Inc (NASDAQ:XM) from Buy to Hold. For the fourth quarter, Qualtrics International had an EPS of $0.03, compared to year-ago quarter EPS of $0.07. At the moment, the stock has a 52-week-high of $30.95 and a 52-week-low of $9.32. Qualtrics International closed at $17.38 at the end of the last trading period.

According to HSBC, the prior rating for TDCX Inc (NYSE:TDCX) was changed from Buy to Hold. In the fourth quarter, TDCX showed an EPS of $0.15, compared to $0.15 from the year-ago quarter. The stock has a 52-week-high of $15.38 and a 52-week-low of $6.52. At the end of the last trading period, TDCX closed at $13.09.

For Edwards Lifesciences Corp (NYSE:EW), Wells Fargo downgraded the previous rating of Overweight to Equal-Weight. Edwards Lifesciences earned $0.64 in the fourth quarter, compared to $0.51 in the year-ago quarter. At the moment, the stock has a 52-week-high of $131.10 and a 52-week-low of $67.13. Edwards Lifesciences closed at $78.92 at the end of the last trading period.

According to Berenberg, the prior rating for Tesla Inc (NASDAQ:TSLA) was changed from Buy to Hold. For the fourth quarter, Tesla had an EPS of $1.19, compared to year-ago quarter EPS of $0.85. The stock has a 52-week-high of $384.29 and a 52-week-low of $101.81. At the end of the last trading period, Tesla closed at $187.71.

B of A Securities downgraded the previous rating for Cara Therapeutics Inc (NASDAQ:CARA) from Neutral to Underperform. Cara Therapeutics earned $0.56 in the fourth quarter, compared to $0.63 in the year-ago quarter. At the moment, the stock has a 52-week-high of $13.96 and a 52-week-low of $6.58. Cara Therapeutics closed at $6.69 at the end of the last trading period.

According to Keefe, Bruyette & Woods, the prior rating for Ares Commercial Real Estate Corp (NYSE:ACRE) was changed from Outperform to Market Perform. For the fourth quarter, Ares Comml Real Est had an EPS of $0.44, compared to year-ago quarter EPS of $0.41. The current stock performance of Ares Comml Real Est shows a 52-week-high of $16.48 and a 52-week-low of $9.90. Moreover, at the end of the last trading period, the closing price was at $11.21.

See all analyst ratings downgrades.

Initiations

PI Financial initiated coverage on Lithium Americas Corp (NYSE:LAC) with a Buy rating. The price target for Lithium Americas is set to $40.00. For the third quarter, Lithium Americas had an EPS of $0.30, compared to year-ago quarter EPS of $0.14. At the moment, the stock has a 52-week-high of $40.39 and a 52-week-low of $17.57. Lithium Americas closed at $23.27 at the end of the last trading period.

With a Buy rating, EF Hutton initiated coverage on inTest Corp (AMEX:INTT). The price target seems to have been set at $22.00 for inTest. inTest earned $0.34 in the fourth quarter, compared to $0.07 in the year-ago quarter. The current stock performance of inTest shows a 52-week-high of $15.98 and a 52-week-low of $6.07. Moreover, at the end of the last trading period, the closing price was at $15.19.

EF Hutton initiated coverage on Clene Inc (NASDAQ:CLNN) with a Buy rating. The price target for Clene is set to $13.00. Clene earned $0.17 in the third quarter, compared to $0.42 in the year-ago quarter. The stock has a 52-week-high of $5.13 and a 52-week-low of $0.87. At the end of the last trading period, Clene closed at $1.27.

With an Outperform rating, Macquarie initiated coverage on Piedmont Lithium Inc (NASDAQ:PLL). The price target seems to have been set at $140.00 for Piedmont Lithium. The stock has a 52-week-high of $79.99 and a 52-week-low of $32.09. At the end of the last trading period, Piedmont Lithium closed at $57.14.

For NAPCO Security Technologies Inc (NASDAQ:NSSC), William Blair initiated coverage, by setting the current rating at Outperform. For the second quarter, NAPCO Security Techs had an EPS of $0.23, compared to year-ago quarter EPS of $0.03. At the moment, the stock has a 52-week-high of $36.78 and a 52-week-low of $15.60. NAPCO Security Techs closed at $33.02 at the end of the last trading period.

Bernstein initiated coverage on Sabre Corp (NASDAQ:SABR) with an Underperform rating. The price target for Sabre is set to $4.00. Sabre earned $0.36 in the fourth quarter, compared to $0.47 in the year-ago quarter. The current stock performance of Sabre shows a 52-week-high of $11.77 and a 52-week-low of $4.46. Moreover, at the end of the last trading period, the closing price was at $5.02.

With a Market Outperform rating, JMP Securities initiated coverage on Lantheus Holdings Inc (NASDAQ:LNTH). The price target seems to have been set at $120.00 for Lantheus Holdings. In the fourth quarter, Lantheus Holdings showed an EPS of $1.37, compared to $0.25 from the year-ago quarter. The current stock performance of Lantheus Holdings shows a 52-week-high of $87.47 and a 52-week-low of $47.46. Moreover, at the end of the last trading period, the closing price was at $72.37.

With an Overweight rating, JP Morgan initiated coverage on Scorpio Tankers Inc (NYSE:STNG). The price target seems to have been set at $87.00 for Scorpio Tankers. In the fourth quarter, Scorpio Tankers showed an EPS of $4.24, compared to $0.79 from the year-ago quarter. The stock has a 52-week-high of $64.20 and a 52-week-low of $16.40. At the end of the last trading period, Scorpio Tankers closed at $60.41.

Goldman Sachs initiated coverage on Axon Enterprise Inc (NASDAQ:AXON) with a Buy rating. The price target for Axon Enterprise is set to $263.00. In the fourth quarter, Axon Enterprise showed an EPS of $0.70, compared to $0.46 from the year-ago quarter. The stock has a 52-week-high of $224.49 and a 52-week-low of $82.49. At the end of the last trading period, Axon Enterprise closed at $222.24.

With a Neutral rating, Cantor Fitzgerald initiated coverage on Karuna Therapeutics Inc (NASDAQ:KRTX). The price target seems to have been set at $214.00 for Karuna Therapeutics. In the fourth quarter, Karuna Therapeutics showed an EPS of $2.22, compared to $0.94 from the year-ago quarter. The current stock performance of Karuna Therapeutics shows a 52-week-high of $278.25 and a 52-week-low of $92.26. Moreover, at the end of the last trading period, the closing price was at $193.48.

See all analyst ratings initiations.

Posted In: ACRE AGNC AXON AY BAC CARA CLNN CMS CNC EW INTT JWN KRTX LAC LNTH NSSC OPAD PLL SABR STNG

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist